You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API FINGOLIMOD LAURYL SULFATE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing FINGOLIMOD LAURYL SULFATE

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Cycle Pharmaceuticals Ltd	TASCENSO ODT	fingolimod lauryl sulfate	70709-062	GELATIN	2036-01-19
Cycle Pharmaceuticals Ltd	TASCENSO ODT	fingolimod lauryl sulfate	70709-062	MANNITOL	2036-01-19
Cycle Pharmaceuticals Ltd	TASCENSO ODT	fingolimod lauryl sulfate	70709-062	MEDIUM-CHAIN TRIGLYCERIDES	2036-01-19
Cycle Pharmaceuticals Ltd	TASCENSO ODT	fingolimod lauryl sulfate	70709-062	SODIUM CHLORIDE	2036-01-19
Cycle Pharmaceuticals Ltd	TASCENSO ODT	fingolimod lauryl sulfate	70709-062	SODIUM LAURYL SULFATE	2036-01-19
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for FINGOLIMOD LAURYL SULFATE

Excipient focus: GELATIN

FINGOLIMOD LAURYL SULFATE drug variants containing GELATIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Cycle Pharmaceuticals Ltd	fingolimod lauryl sulfate	70709-062
>Company	>Ingredient	>NDC

FINGOLIMOD LAURYL SULFATE drug variants not containing GELATIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

FINGOLIMOD LAURYL SULFATE drug variants containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Cycle Pharmaceuticals Ltd	fingolimod lauryl sulfate	70709-062
>Company	>Ingredient	>NDC

FINGOLIMOD LAURYL SULFATE drug variants not containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

FINGOLIMOD LAURYL SULFATE drug variants containing MEDIUM-CHAIN TRIGLYCERIDES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Cycle Pharmaceuticals Ltd	fingolimod lauryl sulfate	70709-062
>Company	>Ingredient	>NDC

FINGOLIMOD LAURYL SULFATE drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

FINGOLIMOD LAURYL SULFATE drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Cycle Pharmaceuticals Ltd	fingolimod lauryl sulfate	70709-062
>Company	>Ingredient	>NDC

FINGOLIMOD LAURYL SULFATE drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM LAURYL SULFATE

FINGOLIMOD LAURYL SULFATE drug variants containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Cycle Pharmaceuticals Ltd	fingolimod lauryl sulfate	70709-062
>Company	>Ingredient	>NDC

FINGOLIMOD LAURYL SULFATE drug variants not containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.